Papillon Pharmaceutical Solutions
0679.971.582 · rovalta.com · 24/09/2026
Papillon Pharmaceutical Solutions
Financial year 2024 · Closed on 31/12/2024
Overview
Identity
Source · BCE/KBOPapillon Pharmaceutical Solutions is a Private company with limited liability incorporated in 2017. Its main activity is: Management consultancy activities. Its registered office is in Gent.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0679.971.582
- Incorporation
- 23/08/2017
- Legal form
- Private company with limited liability
- Registered office
- Edmond Boonenstraat 6
9000 Gent · FlandreSee on map - Contributed capital
- 12 400,00 €
- Latest accounts
- 31/12/2024
Financials
Source · NBB, 6 filingsTrend over 6 financial years
| 2024 | 2023 | 2022 | 2021 | 2019 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 294,7 k € | -24.2% | 388,8 k € | -14.1% | 452,6 k € | +10.6% | 409,1 k € | +55.1% | 263,8 k € |
| EBITDA | 292,3 k € | -24.6% | 387,4 k € | -14.3% | 452,1 k € | +11.0% | 407,4 k € | +75.5% | 232,1 k € |
| Operating result | 269,9 k € | -25.9% | 364 k € | -16.3% | 434,8 k € | +11.3% | 390,6 k € | +80.0% | 217 k € |
| Net result | 203,3 k € | -21.5% | 259 k € | -14.4% | 302,4 k € | +14.4% | 264,2 k € | +78.8% | 147,8 k € |
| Balance sheet | |||||||||
| Equity | 1,5 M € | +15.3% | 1,3 M € | +24.3% | 1,1 M € | +39.6% | 764,6 k € | +136% | 323,7 k € |
| Total assets | 1,7 M € | +20.3% | 1,4 M € | +11.8% | 1,2 M € | +17.5% | 1,1 M € | +50.2% | 701,9 k € |
| Cash | 331,7 k € | -45.6% | 610,2 k € | -5.3% | 644,1 k € | +15.2% | 558,9 k € | +97.7% | 282,6 k € |
| Debts | 136,2 k € | +132% | 58,8 k € | -65.8% | 172 k € | -40.6% | 289,6 k € | -23.4% | 378,2 k € |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20241 active · 1 ended
Active mandates
Ended mandates
Financials
Full financial information
Source · NBB| 2024 | 2023 | 2022 | 2021 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Abridged model |
| Start of the financial year | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2019 | 22/08/2017 |
| Closing of the financial year | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2019 | 31/12/2018 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 17 months |
| Filing date | 30/09/2025 | 29/08/2024 | 31/08/2023 | 31/08/2022 | 31/10/2020 | 31/12/2019 |
| General meeting | 21/06/2025 | 15/06/2024 | 17/06/2023 | 18/06/2022 | 08/09/2020 | 15/06/2019 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for 7 daysAnnual accounts filings
Source · NBB, 6 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/12/2024 | 21/06/2025 | 30/09/2025 | Dutch | |
| Micro model | 31/12/2023 | 15/06/2024 | 29/08/2024 | Dutch | |
| Micro model | 31/12/2022 | 17/06/2023 | 31/08/2023 | Dutch | |
| Micro model | 31/12/2021 | 18/06/2022 | 31/08/2022 | Dutch | |
| Micro model | 31/12/2019 | 08/09/2020 | 31/10/2020 | Dutch | |
| Abridged model | 31/12/2018 | 15/06/2019 | 31/12/2019 | Dutch |
Valuation
Indicative valuation
As an indication, this company is worth
between 1 M€ and 2,5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20241 active · 1 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2024Annual accounts 2024203,3 k €↓
- 2023Annual accounts 2023259 k €↓
- 2022Annual accounts 2022302,4 k €↑
- 2021Annual accounts 2021264,2 k €↑
- 2019Annual accounts 2019147,8 k €↓
- 2018Annual accounts 2018163,5 k €
- 23/08/2017IncorporationPrivate company with limited liability